Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ )p MZ5|+X
{.We%{4V
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© KUf
k5Y
T
x_n$ &
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© %$
^yot
"R$ee^
1.Co-stimulators (or co-stimulating molecules) 877>=Tp|
?o h3t
2.NK-kB @|&P#wd.u
DVYY1!j<
3.Immunoglobulin superfamily <3;/,>^ Pm
cI3uH1;#
4.antigen-presenting cell (APC) %Gn(b1X
R
Nr=M^Zn
5.death domain l}X3uyS
voaRh@DZ%/
6.CCR and CXCR 17G7r\iNYq
nTjQ4y
7.Lectin (or mitogen) Dj>.)n
AKM
\1H3U
8.Clusters of differentiation, CD) U %Aj~K^b
6^['g-\2
9.B7 family +D1;_D
U
MQ"<r,o?:
10.Cytotoxic T lymphocyte, CTL) }6eWdm!B
`c{
i+
11.IL-15 and IL-15 receptor (IL-15R) lN 1 T\
=#1iio&
12.MHC restriction XLFJ?$)Tro
%@*diJ
13.Affinity-chromatography jKQnox+=
l4u`R(!n5
14.Cyctosprin A, CsA QsI>_<r
E](Ood
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ep[7#\}5
Abce]-E
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© W
32mAz;
Wuye:
b!
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ^']xkS
KWy4}7a@,s
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ tTF/$`Q#*
!=cW+=1
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ )F]E[sga
lpve Yz
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© :(A]Bm3
u;~/B[
ÃâÒßѧרҵ£º T
-C2V$1
v8
gg
PI
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ InNuK0@
'!{zO"
1*
Ïû»¯ÄÚ¿Æ£º +Medu?K
`
x1$fkNu
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ N$>g)Ml?
R(r89bTQ
ѪҺ²¡Ñ§×¨Òµ£º f]%$HfF@
fX#Em'Ab[
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿